Recent Finacing
Recent Raise
Encellin develops biocompatible nanoporous cell‑encapsulation devices that house implanted therapeutic cells, permitting biomolecule exchange to enable cell‑based treatments such as islet transplantation for Type 1 diabetes and hypocalcemia.
